MEXICO CITY, July 10, 2012 /PRNewswire/ --Financiera Independencia, S.A.B. de C.V., SOFOM, E.N.R. (BMV: FINDEP; OTC: FNCRY), (Independencia), a leading Mexican microfinance lender of personal loans to lower income segment individuals and working capital loans through group lending microfinance, will hold its fiscal 2012 second quarter conference call on Friday, July 27, 2012 at 11:00 am U.S. ET (10:00 am Mexico City Time). The earnings release for the second quarter ending June 30, 2012 will be issued on Thursday, July 26, 2012.
The conference call can be accessed by dialing 866-393-9621 (U.S./Canada) or 706-758-4196 (international) and entering pass code 99081518.
A replay will be available between 11:25 am ET on July 27 and 11:59 pm ET on August 10, 2012. The replay is accessible by dialing 855-859-2056 (U.S./Canada) or 404-537-3406 (international) and entering pass code 99081518.
A simultaneous webcast of the conference call will be available at http://www.findep.mx
About Financiera Independencia:
Financiera Independencia, S.A.B. de C.V., SOFOM, E.N.R. (Independencia), is a Mexican microfinance lender of personal loans to individuals and working capital loans through group lending microfinance. Independencia provides microcredit loans on an unsecured basis to individuals in the low-income segments in Mexico in urban and rural areas of both the formal and informal economy. As of March 31, 2012, Independencia had a total outstanding loan balance of Ps.7,367.8 million, operated 517 offices in Mexico, Brazil, and the US and had a total labor force of 12,290 people. The Company listed on the Mexican Stock Exchange on November 1, 2007, where it trades under the symbol "FINDEP". On November 30, 2009 Independencia launched a sponsored Level I American Depositary Receipt (ADR) program in the United States. Each ADR represents 15 shares of Independencia common stock and trades over-the-counter (OTC). More information can be found at www.findep.mx
+52 (55) 5229 0291
In the US
SOURCE Financiera Independencia, S.A.B. de C.V., SOFOM, E.N.R.